Feline Injection-Site Sarcoma (FISS): The 3-2-1 Rule, Biopsy and Surgery

Feline Injection-Site Sarcoma (FISS) is an aggressive malignant mesenchymal neoplasm (predominantly fibrosarcoma) arising within feline subcutaneous tissues in response to persistent, dysregulated local inflammation triggered by biologicals, adjuvant vaccines, depot medications, or microchips. Characterized by deep, tentacle-like microscopic infiltration far beyond palpable boundaries, FISS demands prompt detection, advanced cross-sectional imaging, and aggressive oncologic surgical resection with expansive margins.

Sources

This guide is not a substitute for a vet.24h Emergency Vets

Veterinarian palpating and measuring a subcutaneous lump on a cat's distal leg with a caliper during an oncology checkup — Foto: Nekolife

In this guide

Etiopathogenesis and Feline Tissue Susceptibility

Historically linked to adjuvanted feline leukemia virus (FeLV) and rabies vaccines, current veterinary consensus recognizes that any substance inciting localized chronic granulomatous inflammation in genetically susceptible cats can prompt neoplastic transformation of fibroblasts and myofibroblasts. Genetic mutations in tumor suppressor genes, such as TP53, impair the feline immune system's ability to arrest uncontrolled cellular proliferation at injection sites.

The Definitive 3-2-1 Rule for Lumps

To distinguish between a benign post-vaccination inflammatory nodule and an early FISS, veterinary oncology organizations endorse the 3-2-1 Rule:

3 Months: The nodule persists or remains palpable for 3 months or longer post-injection.
2 Centimeters: The subcutaneous mass measures 2 centimeters or larger at any time.
1 Month: The mass continues to increase in size 1 month after initial observation.

Meeting any single criterion warrants immediate diagnostic tissue biopsy (tru-cut or incisional wedge biopsy). Simple "lumpectomies" or marginal "shell-out" excisions are strictly contraindicated, as they disrupt tumor pseudo-capsules and trigger rapid recurrences.

Surgical Protocol and Safe Injection Sites

Curative intent hinges on radical first-attempt surgery:

Wide Lateral Margins: Excision of 3 to 5 cm of macroscopically healthy tissue in all directions around the tumor.
Complete Deep Fascial Plane: En bloc resection of at least one intact fascial plane beneath the tumor base (including underlying abdominal wall fascia or bone if located over vertebrae or scapula).
Distal Limb Vaccinations: Feline vaccination guidelines (AAFP) mandate administering vaccines as distally as possible on the limbs (distal right hind for rabies, distal left hind for FeLV, distal tail for core vaccines) to permit curative limb amputation if a sarcoma arises.

Scientific Sources and References

Hartmann, K., et al. (2015). Feline injection-site sarcoma: ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery, 17(7), 606-613.
Stone, A. E., et al. (2020). 2020 AAHA/AAFP Feline Vaccination Guidelines. Journal of Feline Medicine and Surgery, 22(9), 813-830.
Saba, C. F. (2017). Vaccine-associated sarcomas in cats. Veterinary Clinics of North America: Small Animal Practice, 47(6), 1059-1064.

Nekolife Community